You are here

Jardiance

Eli Lilly's diabetes pill takes market share from J&J, Astra

Yahoo/Reuters

Tue, 01/5/16 - 09:16 pm

Victoza Brings About No Effects To Help Control Heart Failure

Bidness, ETC

Tue, 11/10/15 - 03:54 pm

Boehringer Ingelheim

Lilly diabetes drug cuts heart failure death, hospitalization -study

Yahoo/Reuters

Mon, 11/9/15 - 03:33 pm

Boehringer Ingelheim

J&J says its diabetes drug should have same survival edge as Lilly's

Yahoo/Reuters

Tue, 10/13/15 - 06:15 pm

J&J says Jardiance survival benefit likely to be seen by Invokana

Yahoo/Reuters

Tue, 10/13/15 - 12:13 pm

This Double-Whammy Sent Merck Shares Notably Lower in September

Motley Fool

Fri, 10/9/15 - 11:19 am

Payers want new guidelines, more data before easing access to diabetes' CV star Jardiance

Fierce Pharma

Mon, 10/5/15 - 05:52 pm

payer negotiation

Boehringer Ingelheim

Did Eli Lilly Just Get a Leg Up on Johnson & Johnson?

Motley Fool

Tue, 09/29/15 - 10:28 pm

Eli Lilly Officially Puts Merck on Notice

Motley Fool

Tue, 09/22/15 - 09:50 am

Boehringer Ingelheim

Lilly's Heart Study Sets Up Showdown With Novo's Victoza

Bloomberg

Fri, 09/18/15 - 09:36 pm

Boehringer Ingelheim

Lilly shares rally to near 15-year high on diabetes drug study results

Marketwatch

Thu, 09/17/15 - 05:27 pm

Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana

Fierce Pharma Marketing

Mon, 09/14/15 - 11:01 am

Boehringer Ingelheim

Jardiance and its CV data? They're no knockout punch for stalwart Januvia, Merck says

Fierce Pharma

Wed, 09/2/15 - 10:27 am

Boehringer Ingelheim

Did This Clinical Study Just Show Merck's Best-Selling Drug the Door?

Motley Fool

Sun, 08/30/15 - 11:54 am

clinical trials

Boehringer Ingelheim

SGLT2 inhibitor

Eli Lilly's Diabetes Drug May Halt Heart Disease

Motley Fool

Fri, 08/28/15 - 08:18 am

Boehringer Ingelheim

Merck’s Diabetes Dominance at Risk as Rival Drug Helps Out Heart

Bloomberg

Fri, 08/21/15 - 05:24 pm

Boehringer Ingelheim

The 2013 Merck-Pfizer Diabetes Deal Now Looks Very Savvy

Forbes

Thu, 08/20/15 - 03:14 pm

Lilly, Boehringer diabetes drug reduces cardiovascular risk in trial

Yahoo/Reuters

Thu, 08/20/15 - 08:26 am

Boehringer Ingelheim

FDA warns on newer class of type 2 diabetes drugs

Yahoo/Reuters

Sat, 05/16/15 - 02:04 pm

type 2 diabetes

Boehringer Ingelheim

SGLT2 inhibitor

J&J's Invokana fends off new SGLT2 rivals to hit $278M in Q1

Fierce Pharma Marketing

Wed, 04/15/15 - 09:28 am

SGLT2 inhibitor

Boehringer Ingelheim

Pages